LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 18.95 | 770.25 | 1504 | 1832 | 0.8207 | 0.7077 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 18.95 | 770.25 | 1596 | 1832 | 0.8709 | 0.7908 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 21.17 | 770.25 | 1490 | 2008 | 0.7419 | 0.6116 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 21.17 | 770.25 | 1480 | 2008 | 0.7369 | 0.6038 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 23.39 | 770.25 | 1499 | 2244 | 0.6679 | 0.5396 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 23.39 | 770.25 | 1475 | 2244 | 0.6572 | 0.5236 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 25.62 | 770.25 | 1484 | 2514 | 0.5901 | 0.4684 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 25.62 | 770.25 | 1563 | 2514 | 0.6215 | 0.5137 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 27.84 | 770.25 | 1505 | 2833 | 0.5311 | 0.4282 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 27.84 | 770.25 | 1588 | 2833 | 0.5604 | 0.4696 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 30.06 | 770.25 | 1484 | 3106 | 0.4778 | 0.3854 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 30.06 | 770.25 | 1605 | 3106 | 0.5167 | 0.4404 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 32.28 | 770.25 | 1514 | 3392 | 0.4462 | 0.3715 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 32.28 | 770.25 | 1694 | 3392 | 0.4993 | 0.4455 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 34.50 | 770.25 | 1517 | 3712 | 0.4087 | 0.3482 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 34.50 | 770.25 | 1647 | 3712 | 0.4437 | 0.3979 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 36.73 | 770.25 | 1529 | 4086 | 0.3742 | 0.3295 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 36.73 | 770.25 | 1569 | 4086 | 0.3840 | 0.3439 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 38.95 | 770.25 | 1511 | 4543 | 0.3325 | 0.3010 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 38.95 | 770.25 | 1597 | 4543 | 0.3515 | 0.3295 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 41.17 | 770.25 | 1523 | 5010 | 0.3040 | 0.2870 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 41.17 | 770.25 | 1520 | 5010 | 0.3034 | 0.2861 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 43.39 | 770.25 | 1526 | 5404 | 0.2824 | 0.2754 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 43.39 | 770.25 | 1687 | 5404 | 0.3122 | 0.3217 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 45.61 | 770.25 | 1527 | 5813 | 0.2627 | 0.2645 | MN20160304_L02 | D08 |